SeaStar Medical Holding Corp (ICU)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 250K 500K 750K Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 68K Q4 '24: 67K Q1 '25: 293K Q2 '25: 338K Q3 '25: 183K Q4 '25: 420K Q1 '26: 495K Q2 '26: 615K Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

0 200K 400K 600K Q1 '24: 0 Q2 '24: 0 Q3 '24: 68K Q4 '24: 67K Q1 '25: 293K Q2 '25: 311K Q3 '25: 169K Q4 '25: 408K Q1 '26: 449K Q2 '26: 561K Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -411.4K Q4 '21: -3.7M Q1 '22: -812K Q2 '22: -1.3M Q3 '22: -1.8M Q4 '22: -7.7M Q1 '23: -4.6M Q2 '23: -3.8M Q3 '23: -2.9M Q4 '23: -2.9M Q1 '24: -4M Q2 '24: -4.7M Q3 '24: -4.5M Q4 '24: -4.8M Q1 '25: -3.8M Q2 '25: -1.8M Q3 '25: -3.6M Q4 '25: -3M Q1 '26: -3.6M Q2 '26: -3.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: 236K Q4 '21: -4.6M Q1 '22: -1M Q2 '22: -902K Q3 '22: -1.9M Q4 '22: -8.4M Q1 '23: -7.1M Q2 '23: -2.4M Q3 '23: -7.2M Q4 '23: -9.5M Q1 '24: -12.7M Q2 '24: -3.2M Q3 '24: -4.5M Q4 '24: -4.4M Q1 '25: -3.8M Q2 '25: -2M Q3 '25: -3.5M Q4 '25: -2.9M Q1 '26: -3.5M Q2 '26: -3.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 20K 40K 60K Q3 '23: 0 Q4 '23: 0 Q1 '24: 0 Q2 '24: 0 Q3 '24: 0 Q4 '24: 0 Q1 '25: 0 Q2 '25: 27K Q3 '25: 14K Q4 '25: 12K Q1 '26: 46K Q2 '26: 54K Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow Quarterly

-6M -4M -2M 0 2M 4M 6M Q3 '21: -53.3K Q4 '21: -4.7M Q1 '22: -587K Q2 '22: -991K Q3 '22: -914K Q4 '22: -5.3M Q1 '23: -2.3M Q2 '23: -2.2M Q3 '23: -1.3M Q4 '23: -4.5M Q1 '24: -3.5M Q2 '24: -2.8M Q3 '24: -5M Q4 '24: -4.7M Q1 '25: -2.7M Q2 '25: -3M Q3 '25: -3.8M Q4 '25: -4.1M Q1 '26: -2.8M Q2 '26: -3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '21: 9.7M Q2 '21: 13M Q1 '22: 7.2M Q2 '22: 7.2M Q3 '22: 7.2M Q1 '23: 13M Q2 '23: 597.3K Q3 '23: 801.9K Q1 '24: 2.7M Q2 '24: 3.2M Q3 '24: 4.1M Q1 '25: 8.6M Q2 '25: 11.3M Q3 '25: 26.4M Q1 '26: 3.9M Q2 '26: 4.1M Q2 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-60.00 -40.00 -20.00 0.00 20.00 40.00 60.00 Q4 '22: -1.48 Q1 '23: -1.88 Q2 '23: -5.86 Q3 '23: -14.62 Q4 '23: -42.87 Q1 '24: -47.06 Q2 '24: -43.99 Q3 '24: -36.07 Q4 '24: -7.39 Q1 '25: -3.10 Q2 '25: -2.25 Q3 '25: -1.28 Q4 '25: -6.01 Q1 '26: -6.47 Q2 '26: -7.20 Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.